摘要
In the latest issue of AJKD,Ritchie et al present an analysis of their database registry of ARVD maintained in Manchester,United Kingdom,that indicates that identifiable high-risk presentations with ARVD have distinctly different outcomes and may receive major benefits from stent placement.The current ongoing Cardiovascular Outcomes in Renal Atherosclerotic Lesions(CORAL)trial may provide more concrete data regarding the role of stenting in RAS.What is clear,however,is that the procedural and technical evolution of renal intervention continues.By objectively identifying patients with
In the latest issue of AJKD, Ritchie et al present an analysis of their database registry of ARVD maintained in Manches- ter, United Kingdom, that indicates that identifiable high-risk presentations with ARVD have distinctly different outcomes and may receive major benefits from stent placement. The current ongoing Cardiovascular Outcomes in Renal Atherosclerotic Lesions （CORAL） trial may provide more concrete data regarding the role of stenting in RAS. What is clear, however, is that the procedural and technical evolution of renal intervention continues. By objectively identifying patients with clinical in- dications for revascularization, with hemodynamically significant RAS and reversible renal parenchymal disease, the results of renal artery stenting can continue to improve.
出处
《临床误诊误治》
2014年第3期69-69,共1页
Clinical Misdiagnosis & Mistherapy
